Goldman Sachs’s United States Antimony UAMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.74M Buy
1,341,292
+667,420
+99% +$6.04M ﹤0.01% 3252
2026
Q1
$5.88M Sell
673,872
-670,908
-50% -$5.85M ﹤0.01% 3540
2025
Q4
$6.75M Buy
1,344,780
+1,099,634
+449% +$8.63M ﹤0.01% 3467
2025
Q3
$1.52M Sell
245,146
-331,904
-58% -$1.39M ﹤0.01% 4712
2025
Q2
$1.26M Buy
577,050
+217,358
+60% +$616K ﹤0.01% 4527
2025
Q1
$791K Buy
359,692
+95,811
+36% +$166K ﹤0.01% 4865
2024
Q4
$467K Buy
+263,881
New +$265K ﹤0.01% 5289
2018
Q2
Sell
-12,945
Closed -$3K 6035
2018
Q1
$3K Sell
12,945
-31,594
-71% -$9.37K ﹤0.01% 5830
2017
Q4
$14K Sell
44,539
-42,476
-49% -$11.2K ﹤0.01% 6166
2017
Q3
$25K Sell
87,015
-27,523
-24% -$9.1K ﹤0.01% 6399
2017
Q2
$45K Sell
114,538
-12,666
-10% -$5.32K ﹤0.01% 6381
2017
Q1
$63K Sell
127,204
-85,493
-40% -$34.5K ﹤0.01% 6224
2016
Q4
$53K Sell
212,697
-121,642
-36% -$43.2K ﹤0.01% 6375
2016
Q3
$150K Buy
334,339
+138,944
+71% +$50.5K ﹤0.01% 6006
2016
Q2
$41K Sell
195,395
-17,557
-8% -$4.42K ﹤0.01% 6488
2016
Q1
$48K Buy
212,952
+88,805
+72% +$21.9K ﹤0.01% 6452
2015
Q4
$36K Sell
124,147
-19,628
-14% -$6.68K ﹤0.01% 6687
2015
Q3
$50K Buy
143,775
+45,400
+46% +$25.7K ﹤0.01% 6793
2015
Q2
$67K Sell
98,375
-259
-0.3% -$242 ﹤0.01% 6780
2015
Q1
$67K Sell
98,634
-70,947
-42% -$45.4K ﹤0.01% 6594
2014
Q4
$119K Sell
169,581
-17,640
-9% -$17.2K ﹤0.01% 6501
2014
Q3
$238K Sell
187,221
-27,378
-13% -$40.6K ﹤0.01% 5990
2014
Q2
$305K Buy
214,599
+94,473
+79% +$172K ﹤0.01% 5812
2014
Q1
$219K Sell
120,126
-4,920
-4% -$9.52K ﹤0.01% 6007
2013
Q4
$246K Sell
125,046
-55,061
-31% -$95.5K ﹤0.01% 5832
2013
Q3
$250K Sell
180,107
-3,345
-2% -$3.99K ﹤0.01% 5701
2013
Q2
$204K Buy
+183,452
New +$250K ﹤0.01% 5576

Other funds holding UAMY

Goldman Sachs's UAMY Position: Q2 2026 in Review

Goldman Sachs increased its United States Antimony (UAMY) stake by 99% in Q2 2026, buying an estimated $6.04M and bringing the position to 1,341,292 shares worth $9.74M. The position accounts for ﹤0.01% of the portfolio, ranked #3252.

Goldman Sachs first reported a position in UAMY in Q2 2013 and has held it in 27 quarters since. 238 funds tracked by Wall St. Rank hold UAMY as of Q2 2026.

  • Goldman Sachs held 1,341,292 shares of United States Antimony worth $9.74M as of Q2 2026.
  • Goldman Sachs bought 667,420 United States Antimony shares in Q2 2026, an estimated $6.04M.
  • United States Antimony made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #3252 holding.
  • Goldman Sachs first reported a position in United States Antimony in Q2 2013 and has held it in 27 quarters since.
  • 238 funds tracked by Wall St. Rank held United States Antimony as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.